studies provide compelling evidence that semaglutide use in orthopedic surgery is associated with lower rates of infection, readmission, and revision surgery, likely due to improved metabolic control, reductions in systemic inflammation, and weight loss-driven perioperative risk reduction
Understanding your options helps you advocate appropriately with your healthcare provider
Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes [PubMed record]
At Nulevel Wellness Medspa, peptide protocols are customized based on your lab work, training habits, and metabolic profile
Tirzepatide (15mg, Zepbound): Up to 22.5% body weight reduction over 72 weeks in the SURMOUNT trials
To learn more about Ro's weight loss offering, visit ro.co/weight-loss/serena